Drugs / human hepatocyte transplantation
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01345578 | Mar 2011 → Mar 2022 | metabolic disease | Ira Fox | Terminated | No outcome recorded Stop: Business |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | human hepatocyte transplantation | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01345578 ↗ |
| Action | Restore | “the transplanted cells integrate into the host liver, providing considerable restorative potential.” NCT01345578 ↗ |
| Modality | Cell therapy | “liver cell transplantation” NCT01345578 ↗ |
| Route | Other | “Transplantation of hepatocytes into the liver will be through the portal vein.” NCT01345578 ↗ |